Statement of Consolidated Cash Flows - USD ($)	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2018	Dec. 31, 2017
Cash from Operations
Net income (loss)	$ 470,000,000	$ 642,000,000	$ (74,000,000)
Adjustments to reconcile net income (loss) to cash provided from (used for) operations:
Depreciation and amortization	536,000,000	576,000,000	551,000,000
Deferred income taxes	(19,000,000)	31,000,000	434,000,000
Impairment of goodwill (A and N)	0	0	719,000,000
Restructuring and other charges	620,000,000	9,000,000	165,000,000
Net loss (gain) from investing activities - asset sales	7,000,000	10,000,000	(513,000,000)
Net periodic pension benefit cost (F)	115,000,000	130,000,000	217,000,000
Stock-based compensation	60,000,000	50,000,000	67,000,000
Other	13,000,000	75,000,000	112,000,000
Changes in assets and liabilities, excluding effects of acquisitions, divestitures, and foreign currency translation adjustments:
(Increase) in receivables	(977,000,000)	(1,142,000,000)	(915,000,000)
(Increase) in inventories	(3,000,000)	(74,000,000)	(192,000,000)
Decrease (increase) in prepaid expenses and other current assets	4,000,000	(1,000,000)	11,000,000
(Decrease) increase in accounts payable, trade	(56,000,000)	339,000,000	62,000,000
(Decrease) in accrued expenses	(42,000,000)	(190,000,000)	(116,000,000)
(Decrease) increase in taxes, including income taxes	(2,000,000)	104,000,000	(23,000,000)
Pension contributions	(268,000,000)	(298,000,000)	(310,000,000)
(Increase) in noncurrent assets	(7,000,000)	(20,000,000)	(41,000,000)
(Decrease) in noncurrent liabilities	(45,000,000)	(24,000,000)	(193,000,000)
Cash provided from (used for) operations	406,000,000	217,000,000	(39,000,000)
Financing Activities
Net change in short-term borrowings (original maturities of three months or less)	2,000,000	(7,000,000)	(2,000,000)
Additions to debt (original maturities greater than three months) (P)	400,000,000	600,000,000	816,000,000
Payments on debt (original maturities greater than three months) (P)	(806,000,000)	(1,103,000,000)	(1,634,000,000)
Premiums paid on early redemption of debt (P)	0	(17,000,000)	(52,000,000)
Proceeds from exercise of employee stock options	56,000,000	16,000,000	50,000,000
Dividends paid to shareholders	(57,000,000)	(119,000,000)	(162,000,000)
Distributions to noncontrolling interests	0	0	(14,000,000)
Repurchase of common stock (H)	(1,150,000,000)	0	0
Other	(13,000,000)	(19,000,000)	(17,000,000)
Cash used for financing activities	(1,568,000,000)	(649,000,000)	(1,015,000,000)
Investing Activities
Capital expenditures	(586,000,000)	(768,000,000)	(596,000,000)
Proceeds from the sale of assets and businesses (S)	103,000,000	309,000,000	(9,000,000)
Sales of investments (U)	73,000,000	9,000,000	890,000,000
Cash receipts from sold receivables (K)	995,000,000	1,016,000,000	792,000,000
Other (U)	(2,000,000)	(1,000,000)	243,000,000
Cash provided from investing activities	583,000,000	565,000,000	1,320,000,000
Effect of exchange rate changes on cash, cash equivalents and restricted cash	0	(4,000,000)	9,000,000
Net change in cash, cash equivalents and restricted cash	(579,000,000)	129,000,000	275,000,000
Cash, cash equivalents and restricted cash at beginning of year	2,282,000,000	2,153,000,000	1,878,000,000
Cash, cash equivalents and restricted cash at end of year	$ 1,703,000,000	$ 2,282,000,000	$ 2,153,000,000